Today’s Solutions: October 22, 2021

While CBD is the ingredient in cannabis that gets praise for its healing capabilities, a new study shows THC can also be effective in treating pain. The new study, which was published in the European Journal of Pain, is the first clinical trial that investigated the efficacy of microdosing THC to treat chronic pain.

A microdose is generally known as a subtherapeutic dose of a drug, and the term has more recently become synonymous with tiny, regular dosing of psychedelics such as LSD. 

To measure how THC affects patients, Israeli Pharma-tech company Syqe Medical created a first-of-its-kind product that reportedly enables precise dosing of low-levels of THC. A randomized, double‐blinded, and placebo‐controlled trial recruited a cohort of 27 subjects with chronic neuropathic pain. Across three separate test days, each subject received one inhaled dose, containing either 500 micrograms (0.5 mg) of THC, 1,000 micrograms (1 mg) of THC, or a placebo.

“Both doses, but not the placebo, demonstrated a significant reduction in pain intensity compared with baseline and remained stable for 150‐min,” the researchers write in the published study. “The 1‐mg dose showed a significant pain decrease compared to the placebo.”

As well as showing relevant reductions in subjective pain sensations, the study reports no signs of cognitive impairment across either active dose. Reports of a psychoactive “high” sensation were significantly greater after the 1,000-microgram dose compared to the 500-microgram dose. The 1,000-microgram dose used in the trial is around five to 10 times less than what many consider to the low-end of a psychoactive dose of THC.

The study is not without caveats limiting any broader conclusions about the general efficacy of THC microdosing for chronic pain. The cohort was admittedly small, and the trial only investigated the acute short-term effect of a single THC microdose, so no conclusion can be made about the safety or efficacy of long-term THC microdosing. It is also worth noting the trial was conducted and funded primarily by Syqe Medical, but the study has been independently peer-reviewed and published in a journal.

Solutions News Source Print this article
More of Today's Solutions

FDA takes steps to authorize over-the-counter hearing aids

A new policy from the Food and Drug Administration (FDA) plans to make hearing aids more accessible and affordable in the US. The new policy will make hearing devices available over-the-counter as early as next ... Read More

California grants leatherback sea turtles further protection

For decades, the population of the great Pacific leatherback turtle off the California coast has declined by 5.6 percent per year. To address this devastating loss, California’s Fish and Game Commission recently voted to list ... Read More

This crisis alert app provides crucial information to residents of Kabul

As conditions in Kabul continue to worsen due to the Taliban takeover, residents of the Afghan capital have been struggling to get accurate real-time information about what’s happening in the city. Three and a half ... Read More

World record broken for coldest temperature ever recorded

With our current knowledge of how temperature works there is no upper limit, this means materials can keep getting hotter and hotter to no end. This is not the case for lower temperatures, with the ... Read More

The scientific power of live music

We’re all familiar with the sense of wonder and joy we experience when we hear a song or piece of music we love, but there’s something even more magical about hearing that song performed live. ... Read More

5 Healthy cooking oils for a plant-based diet

Finding the right oil for your diet is a crucial part of maintaining your health—and is especially important for those who stick to a vegan diet. To minimize some of the confusion you may face ... Read More